Versant Capital Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.8K | Sell |
469
-1,051
| -69% | -$101K | ﹤0.01% | 1430 |
|
|
2026
Q1 | $158K | Buy |
1,520
+1,199
| +374% | +$136K | 0.02% | 678 |
|
|
2025
Q4 | $32.4K | Sell |
321
-299
| -48% | -$32.5K | ﹤0.01% | 1339 |
|
|
2025
Q3 | $76.4K | Sell |
620
-402
| -39% | -$49.9K | 0.01% | 831 |
|
|
2025
Q2 | $123K | Buy |
1,022
+675
| +195% | +$90.1K | 0.02% | 604 |
|
|
2025
Q1 | $51.1K | Sell |
347
-174
| -33% | -$26.6K | 0.01% | 851 |
|
|
2024
Q4 | $84.6K | Buy |
521
+162
| +45% | +$26.5K | 0.02% | 367 |
|
|
2024
Q3 | $58.5K | Buy |
+359
| New | +$53.2K | 0.01% | 394 |
|
|
2024
Q2 | – | Sell |
-89
| Closed | -$13.6K | – | 1963 |
|
|
2024
Q1 | $13.6K | Sell |
89
-28
| -24% | -$4.18K | ﹤0.01% | 635 |
|
|
2023
Q4 | $16.7K | Sell |
117
-72
| -38% | -$9.6K | 0.01% | 552 |
|
|
2023
Q3 | $24.8K | Sell |
189
-29
| -13% | -$4.41K | 0.01% | 417 |
|
|
2023
Q2 | $34.7K | Buy |
218
+12
| +6% | +$1.94K | 0.01% | 351 |
|
|
2023
Q1 | $32.6K | Buy |
206
+58
| +39% | +$8.7K | 0.01% | 349 |
|
|
2022
Q4 | $20.8K | Sell |
148
-2
| -1% | -$284 | 0.01% | 439 |
|
|
2022
Q3 | $19K | Sell |
150
-1
| -0.7% | -$144 | 0.01% | 424 |
|
|
2022
Q2 | $21K | Sell |
151
-4
| -3% | -$571 | 0.01% | 414 |
|
|
2022
Q1 | $22K | Buy |
155
+13
| +9% | +$1.99K | 0.01% | 439 |
|
|
2021
Q4 | $25K | Sell |
142
-18
| -11% | -$3K | 0.01% | 423 |
|
|
2021
Q3 | $26K | Sell |
160
-50
| -24% | -$8.61K | 0.01% | 389 |
|
|
2021
Q2 | $38K | Buy |
210
+48
| +30% | +$8.76K | 0.01% | 286 |
|
|
2021
Q1 | $31K | Hold |
162
| – | – | 0.01% | 417 |
|
|
2020
Q4 | $32K | Hold |
162
| – | – | 0.01% | 353 |
|
|
2020
Q3 | $34K | Hold |
162
| – | – | 0.02% | 291 |
|
|
2020
Q2 | $35K | Hold |
162
| – | – | 0.02% | 266 |
|
|
2020
Q1 | $28K | Buy |
162
+11
| +7% | +$1.82K | 0.01% | 284 |
|
|
2019
Q4 | $23K | Sell |
151
-42
| -22% | -$6.28K | 0.01% | 416 |
|
|
2019
Q3 | $29K | Sell |
193
-16
| -8% | -$2.53K | 0.01% | 342 |
|
|
2019
Q2 | $31K | Sell |
209
-62
| -23% | -$9.47K | 0.01% | 319 |
|
|
2019
Q1 | $43K | Buy |
271
+6
| +2% | +$931 | 0.02% | 316 |
|
|
2018
Q4 | $40K | Hold |
265
| – | – | 0.02% | 300 |
|
|
2018
Q3 | $39K | Hold |
265
| – | – | 0.02% | 364 |
|
|
2018
Q2 | $35K | Buy |
265
+10
| +4% | +$1.23K | 0.01% | 404 |
|
|
2018
Q1 | $33K | Sell |
255
-6
| -2% | -$806 | 0.01% | 427 |
|
|
2017
Q4 | $38K | Hold |
261
| – | – | 0.02% | 406 |
|
|
2017
Q3 | $34K | Sell |
261
-27
| -9% | -$3.63K | 0.02% | 375 |
|
|
2017
Q2 | $38K | Sell |
288
-6
| -2% | -$810 | 0.02% | 332 |
|
|
2017
Q1 | $39K | Hold |
294
| – | – | 0.02% | 339 |
|
|
2016
Q4 | $35K | Buy |
294
+8
| +3% | +$943 | 0.02% | 389 |
|
|
2016
Q3 | $35K | Hold |
286
| – | – | 0.02% | 362 |
|
|
2016
Q2 | $39K | Sell |
286
-2
| -0.7% | -$259 | 0.02% | 305 |
|
|
2016
Q1 | $36K | Sell |
288
-6
| -2% | -$763 | 0.02% | 315 |
|
|
2015
Q4 | $37K | Buy |
+294
| New | +$36.5K | 0.02% | 304 |
|
Other funds holding CLX
CIM
SIS
GHAM
CWA
GC
LOPW
YCM
BB
AG
Versant Capital Management's CLX Position: Q2 2026 in Review
Versant Capital Management reduced its Clorox (CLX) stake by 69% in Q2 2026, selling an estimated $101K and leaving 469 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.
Versant Capital Management first reported a position in CLX in Q4 2015 and has held it in 42 quarters since. The position peaked at $158K in Q1 2026. 175 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Versant Capital Management held 469 shares of Clorox worth $44.8K as of Q2 2026.
- Versant Capital Management sold 1,051 Clorox shares in Q2 2026, an estimated $101K.
- Clorox made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1430 holding.
- Versant Capital Management first reported a position in Clorox in Q4 2015 and has held it in 42 quarters since.
- Versant Capital Management's Clorox position peaked at $158K in Q1 2026.
- 175 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.